The novel antipsychotic agent SEP-363856 (Sunovion Pharmaceuticals) has a significant and ongoing effect on negative symptoms in patients with schizophrenia, […]
US Operation Warp Speed’s Slaoui Joins Newly Formed Drug Developer as Lead Scientist
(Reuters) – Moncef Slaoui, formerly the chief scientific adviser for the U.S. government’s Operation Warp Speed COVID-19 vaccine development program, […]